Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area
Background Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote norther...
Saved in:
Published in | BMC cancer Vol. 16; no. 1; p. 346 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
London
BioMed Central
02.06.2016
BioMed Central Ltd |
Subjects | |
Online Access | Get full text |
ISSN | 1471-2407 1471-2407 |
DOI | 10.1186/s12885-016-2390-2 |
Cover
Abstract | Background
Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote northern village and explored if screening could lead to early detection and survival benefits.
Methods
A 5-year population-based study was started in October, 2011 for consented Thai individuals, aged 30–60 years. The screening program comprised blood testing, stool examination and serial ultrasonography every 6 months.
Results
During the first 3 years, 4,225 eligible individuals were enrolled. CCA was detected in 32 patients, with a mean age of 51.9 years (41–62 years), and 21/32 cases were at a curative resectable stage. The prevalence rate of CCA was 165.7 per 100,000 and one- and two-year incidence rate was 236.7/100,000 and 520.7/100,000, respectively. One- and 2-year overall survival rates of CCA patients were 90.9 and 61.5 %, respectively. Prognosis was better in resectable cases with 100 % 1-year and 77.8 % 2-year survival rates. Interestingly, premalignant pathological lesions (stage 0) were identified in 11 cases with 100 % 3-year survival rate. Serum biomarkers and alkaline phosphatase were not sufficient to detect early-stage disease. In 22 patients, stool samples were positive for
Opisthorchis viverrini
, based on polymerase chain reaction.
Conclusion
Detection of premalignant lesions and early-stage resectable CCA by ultrasonography resulted in improved clinical outcome. Ultrasonography should be offered as a first screening tool for CCA in an endemic area until other useful biological markers become available. |
---|---|
AbstractList | Background Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote northern village and explored if screening could lead to early detection and survival benefits. Methods A 5-year population-based study was started in October, 2011 for consented Thai individuals, aged 30-60 years. The screening program comprised blood testing, stool examination and serial ultrasonography every 6 months. Results During the first 3 years, 4,225 eligible individuals were enrolled. CCA was detected in 32 patients, with a mean age of 51.9 years (41-62 years), and 21/32 cases were at a curative resectable stage. The prevalence rate of CCA was 165.7 per 100,000 and one- and two-year incidence rate was 236.7/100,000 and 520.7/100,000, respectively. One- and 2-year overall survival rates of CCA patients were 90.9 and 61.5 %, respectively. Prognosis was better in resectable cases with 100 % 1-year and 77.8 % 2-year survival rates. Interestingly, premalignant pathological lesions (stage 0) were identified in 11 cases with 100 % 3-year survival rate. Serum biomarkers and alkaline phosphatase were not sufficient to detect early-stage disease. In 22 patients, stool samples were positive for Opistorchis viverrini, based on polymerase chain reaction. Conclusion Detection of premalignant lesions and early-stage resectable CCA by ultrasonography resulted in improved clinical outcome. Ultrasonography should be offered as a first screening tool for CCA in an endemic area until other useful biological markers become available. Background Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote northern village and explored if screening could lead to early detection and survival benefits. Methods A 5-year population-based study was started in October, 2011 for consented Thai individuals, aged 30–60 years. The screening program comprised blood testing, stool examination and serial ultrasonography every 6 months. Results During the first 3 years, 4,225 eligible individuals were enrolled. CCA was detected in 32 patients, with a mean age of 51.9 years (41–62 years), and 21/32 cases were at a curative resectable stage. The prevalence rate of CCA was 165.7 per 100,000 and one- and two-year incidence rate was 236.7/100,000 and 520.7/100,000, respectively. One- and 2-year overall survival rates of CCA patients were 90.9 and 61.5 %, respectively. Prognosis was better in resectable cases with 100 % 1-year and 77.8 % 2-year survival rates. Interestingly, premalignant pathological lesions (stage 0) were identified in 11 cases with 100 % 3-year survival rate. Serum biomarkers and alkaline phosphatase were not sufficient to detect early-stage disease. In 22 patients, stool samples were positive for Opisthorchis viverrini , based on polymerase chain reaction. Conclusion Detection of premalignant lesions and early-stage resectable CCA by ultrasonography resulted in improved clinical outcome. Ultrasonography should be offered as a first screening tool for CCA in an endemic area until other useful biological markers become available. Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote northern village and explored if screening could lead to early detection and survival benefits. A 5-year population-based study was started in October, 2011 for consented Thai individuals, aged 30-60 years. The screening program comprised blood testing, stool examination and serial ultrasonography every 6 months. During the first 3 years, 4,225 eligible individuals were enrolled. CCA was detected in 32 patients, with a mean age of 51.9 years (41-62 years), and 21/32 cases were at a curative resectable stage. The prevalence rate of CCA was 165.7 per 100,000 and one- and two-year incidence rate was 236.7/100,000 and 520.7/100,000, respectively. One- and 2-year overall survival rates of CCA patients were 90.9 and 61.5 %, respectively. Prognosis was better in resectable cases with 100 % 1-year and 77.8 % 2-year survival rates. Interestingly, premalignant pathological lesions (stage 0) were identified in 11 cases with 100 % 3-year survival rate. Serum biomarkers and alkaline phosphatase were not sufficient to detect early-stage disease. In 22 patients, stool samples were positive for Opistorchis viverrini, based on polymerase chain reaction. Detection of premalignant lesions and early-stage resectable CCA by ultrasonography resulted in improved clinical outcome. Ultrasonography should be offered as a first screening tool for CCA in an endemic area until other useful biological markers become available. Background Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote northern village and explored if screening could lead to early detection and survival benefits. Methods A 5-year population-based study was started in October, 2011 for consented Thai individuals, aged 30-60 years. The screening program comprised blood testing, stool examination and serial ultrasonography every 6 months. Results During the first 3 years, 4,225 eligible individuals were enrolled. CCA was detected in 32 patients, with a mean age of 51.9 years (41-62 years), and 21/32 cases were at a curative resectable stage. The prevalence rate of CCA was 165.7 per 100,000 and one- and two-year incidence rate was 236.7/100,000 and 520.7/100,000, respectively. One- and 2-year overall survival rates of CCA patients were 90.9 and 61.5 %, respectively. Prognosis was better in resectable cases with 100 % 1-year and 77.8 % 2-year survival rates. Interestingly, premalignant pathological lesions (stage 0) were identified in 11 cases with 100 % 3-year survival rate. Serum biomarkers and alkaline phosphatase were not sufficient to detect early-stage disease. In 22 patients, stool samples were positive for Opistorchis viverrini, based on polymerase chain reaction. Conclusion Detection of premalignant lesions and early-stage resectable CCA by ultrasonography resulted in improved clinical outcome. Ultrasonography should be offered as a first screening tool for CCA in an endemic area until other useful biological markers become available. Keywords: Cholangiocarcinoma, Premalignant lesions, Cancer screening, Early detection, Ultrasonography, Tumor markers Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote northern village and explored if screening could lead to early detection and survival benefits. A 5-year population-based study was started in October, 2011 for consented Thai individuals, aged 30-60 years. The screening program comprised blood testing, stool examination and serial ultrasonography every 6 months. During the first 3 years, 4,225 eligible individuals were enrolled. CCA was detected in 32 patients, with a mean age of 51.9 years (41-62 years), and 21/32 cases were at a curative resectable stage. The prevalence rate of CCA was 165.7 per 100,000 and one- and two-year incidence rate was 236.7/100,000 and 520.7/100,000, respectively. One- and 2-year overall survival rates of CCA patients were 90.9 and 61.5 %, respectively. Prognosis was better in resectable cases with 100 % 1-year and 77.8 % 2-year survival rates. Interestingly, premalignant pathological lesions (stage 0) were identified in 11 cases with 100 % 3-year survival rate. Serum biomarkers and alkaline phosphatase were not sufficient to detect early-stage disease. In 22 patients, stool samples were positive for Opistorchis viverrini, based on polymerase chain reaction. Detection of premalignant lesions and early-stage resectable CCA by ultrasonography resulted in improved clinical outcome. Ultrasonography should be offered as a first screening tool for CCA in an endemic area until other useful biological markers become available. Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote northern village and explored if screening could lead to early detection and survival benefits.BACKGROUNDThailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable stage and presently no optimal screening test for CCA has been established. We determined the prevalence of CCA in a remote northern village and explored if screening could lead to early detection and survival benefits.A 5-year population-based study was started in October, 2011 for consented Thai individuals, aged 30-60 years. The screening program comprised blood testing, stool examination and serial ultrasonography every 6 months.METHODSA 5-year population-based study was started in October, 2011 for consented Thai individuals, aged 30-60 years. The screening program comprised blood testing, stool examination and serial ultrasonography every 6 months.During the first 3 years, 4,225 eligible individuals were enrolled. CCA was detected in 32 patients, with a mean age of 51.9 years (41-62 years), and 21/32 cases were at a curative resectable stage. The prevalence rate of CCA was 165.7 per 100,000 and one- and two-year incidence rate was 236.7/100,000 and 520.7/100,000, respectively. One- and 2-year overall survival rates of CCA patients were 90.9 and 61.5 %, respectively. Prognosis was better in resectable cases with 100 % 1-year and 77.8 % 2-year survival rates. Interestingly, premalignant pathological lesions (stage 0) were identified in 11 cases with 100 % 3-year survival rate. Serum biomarkers and alkaline phosphatase were not sufficient to detect early-stage disease. In 22 patients, stool samples were positive for Opistorchis viverrini, based on polymerase chain reaction.RESULTSDuring the first 3 years, 4,225 eligible individuals were enrolled. CCA was detected in 32 patients, with a mean age of 51.9 years (41-62 years), and 21/32 cases were at a curative resectable stage. The prevalence rate of CCA was 165.7 per 100,000 and one- and two-year incidence rate was 236.7/100,000 and 520.7/100,000, respectively. One- and 2-year overall survival rates of CCA patients were 90.9 and 61.5 %, respectively. Prognosis was better in resectable cases with 100 % 1-year and 77.8 % 2-year survival rates. Interestingly, premalignant pathological lesions (stage 0) were identified in 11 cases with 100 % 3-year survival rate. Serum biomarkers and alkaline phosphatase were not sufficient to detect early-stage disease. In 22 patients, stool samples were positive for Opistorchis viverrini, based on polymerase chain reaction.Detection of premalignant lesions and early-stage resectable CCA by ultrasonography resulted in improved clinical outcome. Ultrasonography should be offered as a first screening tool for CCA in an endemic area until other useful biological markers become available.CONCLUSIONDetection of premalignant lesions and early-stage resectable CCA by ultrasonography resulted in improved clinical outcome. Ultrasonography should be offered as a first screening tool for CCA in an endemic area until other useful biological markers become available. |
ArticleNumber | 346 |
Audience | Academic |
Author | Worakitsitisatorn, Akeanong Yimyaem, Maneenop Siripongsakun, Surachate Chanwat, Rawisak Wittayasak, Kasiruck Sungkasubun, Prakongboon Singharuksa, Sutida Auewarakul, Chirayu U. Soonklang, Kamonwan Vidhyarkorn, Sirachat Bunchaliew, Chairat Sricharunrat, Thaniya Mahidol, Chulabhorn Charoenphattharaphesat, Sirima Akkarachinorate, Kunlayanee Sornsamdang, Gaidganok Molek, Ruechuta |
Author_xml | – sequence: 1 givenname: Prakongboon surname: Sungkasubun fullname: Sungkasubun, Prakongboon organization: Chulabhorn Hospital – sequence: 2 givenname: Surachate surname: Siripongsakun fullname: Siripongsakun, Surachate organization: Chulabhorn Hospital – sequence: 3 givenname: Kunlayanee surname: Akkarachinorate fullname: Akkarachinorate, Kunlayanee organization: Ban Luang Hospital – sequence: 4 givenname: Sirachat surname: Vidhyarkorn fullname: Vidhyarkorn, Sirachat organization: Chulabhorn Hospital – sequence: 5 givenname: Akeanong surname: Worakitsitisatorn fullname: Worakitsitisatorn, Akeanong organization: Chulabhorn Hospital – sequence: 6 givenname: Thaniya surname: Sricharunrat fullname: Sricharunrat, Thaniya organization: Chulabhorn Hospital – sequence: 7 givenname: Sutida surname: Singharuksa fullname: Singharuksa, Sutida organization: Chulabhorn Hospital – sequence: 8 givenname: Rawisak surname: Chanwat fullname: Chanwat, Rawisak organization: National Cancer Institute of Thailand – sequence: 9 givenname: Chairat surname: Bunchaliew fullname: Bunchaliew, Chairat organization: National Cancer Institute of Thailand – sequence: 10 givenname: Sirima surname: Charoenphattharaphesat fullname: Charoenphattharaphesat, Sirima organization: Chulabhorn Hospital – sequence: 11 givenname: Ruechuta surname: Molek fullname: Molek, Ruechuta organization: Chulabhorn Hospital – sequence: 12 givenname: Maneenop surname: Yimyaem fullname: Yimyaem, Maneenop organization: Chulabhorn Hospital – sequence: 13 givenname: Gaidganok surname: Sornsamdang fullname: Sornsamdang, Gaidganok organization: Chulabhorn Hospital – sequence: 14 givenname: Kamonwan surname: Soonklang fullname: Soonklang, Kamonwan organization: Chulabhorn Hospital – sequence: 15 givenname: Kasiruck surname: Wittayasak fullname: Wittayasak, Kasiruck organization: Chulabhorn Hospital – sequence: 16 givenname: Chirayu U. surname: Auewarakul fullname: Auewarakul, Chirayu U. organization: Chulabhorn Hospital, Faculty of Medicine Siriraj Hospital, Mahidol University – sequence: 17 givenname: Chulabhorn surname: Mahidol fullname: Mahidol, Chulabhorn email: cmah2500@gmail.com organization: Chulabhorn Hospital, Faculty of Medicine Siriraj Hospital, Mahidol University, Chulabhorn Research Institute |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/27251649$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkm1r1EAUhYNUbLv6A_wiA4IomDozm1c_CKX4UigIaj8Pd2duslNmZ9KZydb9h_4sZ7ur3S0qEkhC8pxzk3PucXZgncUse8roCWNN9SYw3jRlTlmV82lLc_4gO2JFzXJe0Ppg5_4wOw7hilJWN7R5lB3ympesKtqj7MeliR6CG60iQXpEq21POueJnDsDttdOgpfaugUQ6UajiMKIMpLB4wKM7i3YSAwG7WwgkGwQvFnlIUKPROmAEDCQGx3nJIx-qZdgyAwtdjqGtwTI4IbRQEzyfJZQlYxdGNIEvUQS4qhWxHWkeM15mQxmV-lNINqmUQStwoWWBDzC4-xhBybgk-11kl1-eP_t7FN-8fnj-dnpRS4rymMOCmZMVl3XYKF4VUyhqKFE3nDGlZLIgLaqhGrGq5Y2qpAMZIuyZdOCVp2C6STjG9_RDrC6AWPE4PUC_EowKta1iE0tItUi1rWk0yR7txEN42yBaYxNod8JHWix_8bquejdUhRNS0vWJoOXWwPvrkcMUSx0kGhSQ-jGIFjdTlvGWFsm9Pk99MqN3qZMBGsorRmdsuqO6sGg0LZzaa5cm4rTomqatmHl-rtP_kCl4zZ3ty4xPd8TvNoTJCbi99jDGII4__pln32xw84RTJwHZ8b1KoR98Nluer9j-7XFCWAbQKbVCR67_6qkvqeROt6uYfpFbf6p3G5ASFNsj34n4L-KfgJKXShw |
CitedBy_id | crossref_primary_10_1111_jog_13402 crossref_primary_10_3233_CBM_210170 crossref_primary_10_1016_j_jcjd_2020_09_008 crossref_primary_10_1016_j_parint_2016_11_011 crossref_primary_10_1016_j_parepi_2024_e00391 crossref_primary_10_4103_jcrt_JCRT_1703_20 crossref_primary_10_3389_fmed_2022_893252 crossref_primary_10_1038_s41598_022_17794_9 crossref_primary_10_1016_j_jhep_2023_03_010 crossref_primary_10_1007_s00261_019_01951_2 crossref_primary_10_3390_pathogens9110971 crossref_primary_10_1016_j_gtc_2018_01_002 crossref_primary_10_1016_j_hpb_2022_06_004 crossref_primary_10_1016_j_livres_2022_09_001 crossref_primary_10_1016_j_hpb_2019_10_010 crossref_primary_10_1111_jgh_14074 crossref_primary_10_1016_j_parint_2016_12_005 crossref_primary_10_1016_j_heliyon_2024_e38191 crossref_primary_10_1371_journal_pone_0246490 crossref_primary_10_1016_j_cmpb_2021_106265 crossref_primary_10_1186_s12885_021_08247_z crossref_primary_10_1038_srep42744 crossref_primary_10_3390_ijms21030814 crossref_primary_10_7759_cureus_62531 crossref_primary_10_3347_kjp_2017_55_3_295 crossref_primary_10_1007_s10396_024_01491_3 |
Cites_doi | 10.1016/0035-9203(91)90055-4 10.3322/caac.20107 10.1016/j.trecan.2015.08.011 10.1038/ncomms5378 10.1007/s005340050177 10.1046/j.1365-2168.2002.02143.x 10.1016/j.jhep.2006.09.001 10.1007/s005340050095 10.1038/sj.bjc.6603127 10.14218/JCTH.2015.00012 10.1200/JCO.2005.05.2308 10.1158/1055-9965.EPI-05-0811 10.1371/journal.pmed.0040201 10.7314/APJCP.2012.14.11.7029 10.1002/jhbp.63 10.1007/s00432-010-0971-z 10.1001/jama.2010.1525 10.1016/S0168-8278(02)00297-0 10.1097/MOG.0b013e3282fbf9b3 10.1038/ng.2273 10.3748/wjg.v18.i5.458 10.1158/1538-7445.AM2015-LB-173 10.1002/jhbp.74 10.1111/j.1349-7006.2009.01458.x 10.1053/jhep.2001.25087 10.1093/jnci/djj234 10.1016/j.cld.2007.11.003 10.1016/j.parint.2011.06.007 10.1055/s-0034-1394144 10.3748/wjg.14.6458 10.1097/SLA.0b013e318176c4d3 10.1002/cncr.28312 |
ContentType | Journal Article |
Copyright | The Author(s). 2016 COPYRIGHT 2016 BioMed Central Ltd. Copyright BioMed Central 2016 |
Copyright_xml | – notice: The Author(s). 2016 – notice: COPYRIGHT 2016 BioMed Central Ltd. – notice: Copyright BioMed Central 2016 |
DBID | C6C AAYXX CITATION CGR CUY CVF ECM EIF NPM ISR 3V. 7TO 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA AZQEC BENPR CCPQU DWQXO FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI 7X8 5PM ADTOC UNPAY |
DOI | 10.1186/s12885-016-2390-2 |
DatabaseName | Springer Nature OA Free Journals CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Science ProQuest Central (Corporate) Oncogenes and Growth Factors Abstracts Health & Medical Collection (ProQuest) ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni Edition) ProQuest Central UK/Ireland ProQuest Central Essentials ProQuest Central ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) Health & Medical Collection (Alumni Edition) Medical Database ProQuest Central Premium ProQuest One Academic (New) Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition MEDLINE - Academic PubMed Central (Full Participant titles) Unpaywall for CDI: Periodical Content Unpaywall |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Publicly Available Content Database Oncogenes and Growth Factors Abstracts ProQuest One Academic Middle East (New) ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Publicly Available Content Database MEDLINE MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: C6C name: Springer Nature OA Free Journals url: http://www.springeropen.com/ sourceTypes: Publisher – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 4 dbid: UNPAY name: Unpaywall url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/ sourceTypes: Open Access Repository – sequence: 5 dbid: BENPR name: ProQuest Central url: http://www.proquest.com/pqcentral?accountid=15518 sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2407 |
ExternalDocumentID | 10.1186/s12885-016-2390-2 PMC4890519 4105387541 A468898152 27251649 10_1186_s12885_016_2390_2 |
Genre | Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Thailand |
GeographicLocations_xml | – name: Thailand |
GrantInformation_xml | – fundername: Chulabhorn Hospital – fundername: ; |
GroupedDBID | --- 0R~ 23N 2WC 4.4 53G 5VS 6J9 6PF 7X7 88E 8FI 8FJ AAFWJ AAJSJ AASML AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACMJI ACPRK ACUHS ADBBV ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AHBYD AHMBA AHSBF AHYZX ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C6C CCPQU CS3 DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR IHW INH INR ISR ITC KQ8 M1P M48 M~E O5R O5S OK1 OVT P2P PGMZT PHGZM PHGZT PIMPY PJZUB PPXIY PQQKQ PROAC PSQYO PUEGO RBZ RNS ROL RPM RSV SBL SOJ SV3 TR2 TUS U2A UKHRP W2D WOQ WOW XSB AAYXX CITATION -A0 3V. ACRMQ ADINQ ALIPV C24 CGR CUY CVF ECM EIF NPM PMFND 7TO 7XB 8FK AZQEC DWQXO H94 K9. PKEHL PQEST PQUKI 7X8 5PM 2VQ ADTOC C1A IPNFZ LGEZI LOTEE NADUK NXXTH RIG UNPAY |
ID | FETCH-LOGICAL-c602t-adab1c6ff8e4d2643a47a5e28212ddce1a09d5a6b26908d4c1ac9ec913406fda3 |
IEDL.DBID | M48 |
ISSN | 1471-2407 |
IngestDate | Wed Oct 01 16:04:31 EDT 2025 Tue Sep 30 16:57:04 EDT 2025 Fri Sep 05 10:27:58 EDT 2025 Fri Jul 25 02:00:51 EDT 2025 Tue Jun 17 22:05:39 EDT 2025 Tue Jun 10 21:04:41 EDT 2025 Fri Jun 27 05:47:25 EDT 2025 Thu May 22 21:24:15 EDT 2025 Thu Jan 02 22:25:10 EST 2025 Wed Oct 01 03:44:32 EDT 2025 Thu Apr 24 23:00:58 EDT 2025 Sat Sep 06 07:24:36 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Tumor markers Premalignant lesions Cholangiocarcinoma Early detection Ultrasonography Cancer screening |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. cc-by |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c602t-adab1c6ff8e4d2643a47a5e28212ddce1a09d5a6b26908d4c1ac9ec913406fda3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1186/s12885-016-2390-2 |
PMID | 27251649 |
PQID | 1800710316 |
PQPubID | 44074 |
ParticipantIDs | unpaywall_primary_10_1186_s12885_016_2390_2 pubmedcentral_primary_oai_pubmedcentral_nih_gov_4890519 proquest_miscellaneous_1793911195 proquest_journals_1800710316 gale_infotracmisc_A468898152 gale_infotracacademiconefile_A468898152 gale_incontextgauss_ISR_A468898152 gale_healthsolutions_A468898152 pubmed_primary_27251649 crossref_primary_10_1186_s12885_016_2390_2 crossref_citationtrail_10_1186_s12885_016_2390_2 springer_journals_10_1186_s12885_016_2390_2 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2016-06-02 |
PublicationDateYYYYMMDD | 2016-06-02 |
PublicationDate_xml | – month: 06 year: 2016 text: 2016-06-02 day: 02 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationTitle | BMC cancer |
PublicationTitleAbbrev | BMC Cancer |
PublicationTitleAlternate | BMC Cancer |
PublicationYear | 2016 |
Publisher | BioMed Central BioMed Central Ltd |
Publisher_xml | – name: BioMed Central – name: BioMed Central Ltd |
References | T Patel (2390_CR2) 2001; 33 T Nitta (2390_CR26) 2015; 8 Y Ustundag (2390_CR1) 2008; 14 J West (2390_CR3) 2006; 94 2390_CR27 M Sato (2390_CR35) 2010; 41 2390_CR23 2390_CR22 2390_CR21 2390_CR20 I Endo (2390_CR12) 2008; 248 JS Chang (2390_CR29) 2013; 8 N Thunyaharn (2390_CR9) 2013; 14 J Chaisaingmongkol (2390_CR40) 2015; 75 N Khuntikeo (2390_CR11) 2014; 21 ND Young (2390_CR33) 2014; 5 G Kabbach (2390_CR41) 2015; 3 V Vatanasapt (2390_CR17) 1993 B Sripa (2390_CR31) 2007; 4 CK Ong (2390_CR39) 2012; 44 HR Shin (2390_CR14) 2010; 101 AR Yusoff (2390_CR25) 2012; 18 P Watanapa (2390_CR32) 2002; 89 TM Welzel (2390_CR5) 2006; 98 H Suzuki (2390_CR28) 2000; 7 B Sripa (2390_CR19) 2008; 24 T Uttaravichien (2390_CR10) 1999; 6 SK Maithel (2390_CR24) 2013; 119 BR Blechacz (2390_CR8) 2008; 12 AK Singal (2390_CR30) 2011; 137 ST Hong (2390_CR34) 2012; 61 P Yongvanit (2390_CR38) 2014; 21 F Kamangar (2390_CR15) 2006; 24 S Rizvi (2390_CR42) 2014; 34 S Pungpak (2390_CR37) 1991; 85 F Mihalache (2390_CR13) 2010; 19 KA McGlynn (2390_CR6) 2006; 15 A Jemal (2390_CR16) 2011; 61 M Carpelan-Holmström (2390_CR36) 2001; 22 H Malhi (2390_CR7) 2006; 45 PJ Brindley (2390_CR18) 2015; 1 SA Khan (2390_CR4) 2002; 37 20085587 - Cancer Sci. 2010 Mar;101(3):579-85 26618199 - Trends Cancer. 2015 Nov 1;1(3):174-182 19030196 - World J Gastroenterol. 2008 Nov 14;14(42):6458-66 10398899 - J Hepatobiliary Pancreat Surg. 1999;6(2):128-35 21296855 - CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 23963845 - Cancer. 2013 Nov 15;119(22):3929-42 24408859 - J Hepatobiliary Pancreat Sci. 2014 May;21(5):309-15 26623263 - J Clin Transl Hepatol. 2015 Sep 28;3(3):169-81 21741496 - Parasitol Int. 2012 Mar;61(1):17-24 16788161 - J Natl Cancer Inst. 2006 Jun 21;98(12):873-5 16736026 - Br J Cancer. 2006 Jun 5;94(11):1751-8 1653472 - Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):277-9 12174919 - Anticancer Res. 2002 Jul-Aug;22(4):2311-6 17622191 - PLoS Med. 2007 Jul;4(7):e201 26339398 - Int J Clin Exp Pathol. 2015 Jul 01;8(7):8284-90 20578479 - Southeast Asian J Trop Med Public Health. 2010 Jan;41(1):28-35 16775181 - Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203 16682732 - J Clin Oncol. 2006 May 10;24(14):2137-50 12153620 - Br J Surg. 2002 Aug;89(8):962-70 18580211 - Ann Surg. 2008 Jul;248(1):84-96 21207060 - J Cancer Res Clin Oncol. 2011 Jul;137(7):1071-8 20922193 - J Gastrointestin Liver Dis. 2010 Sep;19(3):285-90 25007141 - Nat Commun. 2014 Jul 09;5:4378 24464976 - J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):521-4 12445422 - J Hepatol. 2002 Dec;37(6):806-13 17030071 - J Hepatol. 2006 Dec;45(6):856-67 22561520 - Nat Genet. 2012 May 06;44(6):690-3 18242501 - Clin Liver Dis. 2008 Feb;12(1):131-50, ix 22346252 - World J Gastroenterol. 2012 Feb 7;18(5):458-65 23894567 - PLoS One. 2013 Jul 22;8(7):e69981 10982615 - J Hepatobiliary Pancreat Surg. 2000;7(2):206-11 25369307 - Semin Liver Dis. 2014 Nov;34(4):456-64 18408464 - Curr Opin Gastroenterol. 2008 May;24(3):349-56 11391522 - Hepatology. 2001 Jun;33(6):1353-7 24377644 - Asian Pac J Cancer Prev. 2013;14(11):7029-32 |
References_xml | – volume: 22 start-page: 2311 issue: 4 year: 2001 ident: 2390_CR36 publication-title: Anticancer Res – volume: 85 start-page: 277 issue: 2 year: 1991 ident: 2390_CR37 publication-title: Trans R Soc Trop Med Hyg doi: 10.1016/0035-9203(91)90055-4 – volume: 61 start-page: 69 issue: 2 year: 2011 ident: 2390_CR16 publication-title: CA Cancer J Clin doi: 10.3322/caac.20107 – volume: 1 start-page: 174 issue: 3 year: 2015 ident: 2390_CR18 publication-title: Trends Cancer doi: 10.1016/j.trecan.2015.08.011 – volume: 5 start-page: 4378 year: 2014 ident: 2390_CR33 publication-title: Nat Commun doi: 10.1038/ncomms5378 – volume: 7 start-page: 206 issue: 2 year: 2000 ident: 2390_CR28 publication-title: J Hepatobiliary Pancreat Surg doi: 10.1007/s005340050177 – start-page: 88 volume-title: Cancer in Thailand 1988–1991 (No. 16) year: 1993 ident: 2390_CR17 – ident: 2390_CR20 – volume: 89 start-page: 962 issue: 8 year: 2002 ident: 2390_CR32 publication-title: Br J Surg doi: 10.1046/j.1365-2168.2002.02143.x – volume: 45 start-page: 856 issue: 6 year: 2006 ident: 2390_CR7 publication-title: J Hepatol doi: 10.1016/j.jhep.2006.09.001 – volume: 8 start-page: 8284 issue: 7 year: 2015 ident: 2390_CR26 publication-title: Int J Clin Exp Pathol – volume: 6 start-page: 128 issue: 2 year: 1999 ident: 2390_CR10 publication-title: J Hepatobiliary Pancreat Surg doi: 10.1007/s005340050095 – volume: 8 issue: 7 year: 2013 ident: 2390_CR29 publication-title: PLoS One – ident: 2390_CR23 – volume: 94 start-page: 1751 issue: 11 year: 2006 ident: 2390_CR3 publication-title: Br J Cancer doi: 10.1038/sj.bjc.6603127 – ident: 2390_CR27 – volume: 3 start-page: 169 issue: 3 year: 2015 ident: 2390_CR41 publication-title: J Clin Transl Hepatol doi: 10.14218/JCTH.2015.00012 – volume: 24 start-page: 2137 issue: 14 year: 2006 ident: 2390_CR15 publication-title: J Clin Oncol doi: 10.1200/JCO.2005.05.2308 – volume: 15 start-page: 1198 issue: 6 year: 2006 ident: 2390_CR6 publication-title: Cancer Epidemiol Biomarkers Prev doi: 10.1158/1055-9965.EPI-05-0811 – volume: 4 issue: 7 year: 2007 ident: 2390_CR31 publication-title: PLoS Med doi: 10.1371/journal.pmed.0040201 – volume: 14 start-page: 7029 issue: 11 year: 2013 ident: 2390_CR9 publication-title: Asian Pac J Cancer Prev doi: 10.7314/APJCP.2012.14.11.7029 – volume: 21 start-page: 309 issue: 5 year: 2014 ident: 2390_CR38 publication-title: J Hepatobiliary Pancreat Sci doi: 10.1002/jhbp.63 – volume: 19 start-page: 285 issue: 3 year: 2010 ident: 2390_CR13 publication-title: J Gastrointestin Liver Dis – volume: 41 start-page: 28 issue: 1 year: 2010 ident: 2390_CR35 publication-title: Southeast Asian J Trop Med Public Health – volume: 137 start-page: 1071 issue: 7 year: 2011 ident: 2390_CR30 publication-title: J Cancer Res Clin Oncol doi: 10.1007/s00432-010-0971-z – ident: 2390_CR22 doi: 10.1001/jama.2010.1525 – volume: 37 start-page: 806 issue: 6 year: 2002 ident: 2390_CR4 publication-title: J Hepatol doi: 10.1016/S0168-8278(02)00297-0 – volume: 24 start-page: 349 issue: 3 year: 2008 ident: 2390_CR19 publication-title: Curr Opin Gastroenterol doi: 10.1097/MOG.0b013e3282fbf9b3 – volume: 44 start-page: 690 issue: 6 year: 2012 ident: 2390_CR39 publication-title: Nat Genet doi: 10.1038/ng.2273 – ident: 2390_CR21 – volume: 18 start-page: 458 issue: 5 year: 2012 ident: 2390_CR25 publication-title: World J Gastroenterol doi: 10.3748/wjg.v18.i5.458 – volume: 75 start-page: LB-173 issue: 15 Supplement year: 2015 ident: 2390_CR40 publication-title: Cancer Res doi: 10.1158/1538-7445.AM2015-LB-173 – volume: 21 start-page: 521 issue: 8 year: 2014 ident: 2390_CR11 publication-title: J Hepatobiliary Pancreat Sci doi: 10.1002/jhbp.74 – volume: 101 start-page: 579 issue: 3 year: 2010 ident: 2390_CR14 publication-title: Cancer Sci doi: 10.1111/j.1349-7006.2009.01458.x – volume: 33 start-page: 1353 issue: 6 year: 2001 ident: 2390_CR2 publication-title: Hepatology doi: 10.1053/jhep.2001.25087 – volume: 98 start-page: 873 issue: 12 year: 2006 ident: 2390_CR5 publication-title: J Natl Cancer Inst doi: 10.1093/jnci/djj234 – volume: 12 start-page: 131 issue: 1 year: 2008 ident: 2390_CR8 publication-title: Clin Liver Dis doi: 10.1016/j.cld.2007.11.003 – volume: 61 start-page: 17 issue: 1 year: 2012 ident: 2390_CR34 publication-title: Parasitol Int doi: 10.1016/j.parint.2011.06.007 – volume: 34 start-page: 456 issue: 4 year: 2014 ident: 2390_CR42 publication-title: Semin Liver Dis doi: 10.1055/s-0034-1394144 – volume: 14 start-page: 6458 issue: 42 year: 2008 ident: 2390_CR1 publication-title: World J Gastroenterol doi: 10.3748/wjg.14.6458 – volume: 248 start-page: 84 issue: 1 year: 2008 ident: 2390_CR12 publication-title: Ann Surg doi: 10.1097/SLA.0b013e318176c4d3 – volume: 119 start-page: 3929 issue: 22 year: 2013 ident: 2390_CR24 publication-title: Cancer doi: 10.1002/cncr.28312 – reference: 23963845 - Cancer. 2013 Nov 15;119(22):3929-42 – reference: 16736026 - Br J Cancer. 2006 Jun 5;94(11):1751-8 – reference: 23894567 - PLoS One. 2013 Jul 22;8(7):e69981 – reference: 24464976 - J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):521-4 – reference: 16682732 - J Clin Oncol. 2006 May 10;24(14):2137-50 – reference: 24377644 - Asian Pac J Cancer Prev. 2013;14(11):7029-32 – reference: 16788161 - J Natl Cancer Inst. 2006 Jun 21;98(12):873-5 – reference: 18408464 - Curr Opin Gastroenterol. 2008 May;24(3):349-56 – reference: 21207060 - J Cancer Res Clin Oncol. 2011 Jul;137(7):1071-8 – reference: 17030071 - J Hepatol. 2006 Dec;45(6):856-67 – reference: 19030196 - World J Gastroenterol. 2008 Nov 14;14(42):6458-66 – reference: 1653472 - Trans R Soc Trop Med Hyg. 1991 Mar-Apr;85(2):277-9 – reference: 18242501 - Clin Liver Dis. 2008 Feb;12(1):131-50, ix – reference: 26339398 - Int J Clin Exp Pathol. 2015 Jul 01;8(7):8284-90 – reference: 12153620 - Br J Surg. 2002 Aug;89(8):962-70 – reference: 12174919 - Anticancer Res. 2002 Jul-Aug;22(4):2311-6 – reference: 10982615 - J Hepatobiliary Pancreat Surg. 2000;7(2):206-11 – reference: 26623263 - J Clin Transl Hepatol. 2015 Sep 28;3(3):169-81 – reference: 25007141 - Nat Commun. 2014 Jul 09;5:4378 – reference: 11391522 - Hepatology. 2001 Jun;33(6):1353-7 – reference: 20922193 - J Gastrointestin Liver Dis. 2010 Sep;19(3):285-90 – reference: 12445422 - J Hepatol. 2002 Dec;37(6):806-13 – reference: 21296855 - CA Cancer J Clin. 2011 Mar-Apr;61(2):69-90 – reference: 21741496 - Parasitol Int. 2012 Mar;61(1):17-24 – reference: 16775181 - Cancer Epidemiol Biomarkers Prev. 2006 Jun;15(6):1198-203 – reference: 26618199 - Trends Cancer. 2015 Nov 1;1(3):174-182 – reference: 18580211 - Ann Surg. 2008 Jul;248(1):84-96 – reference: 20578479 - Southeast Asian J Trop Med Public Health. 2010 Jan;41(1):28-35 – reference: 10398899 - J Hepatobiliary Pancreat Surg. 1999;6(2):128-35 – reference: 22346252 - World J Gastroenterol. 2012 Feb 7;18(5):458-65 – reference: 17622191 - PLoS Med. 2007 Jul;4(7):e201 – reference: 24408859 - J Hepatobiliary Pancreat Sci. 2014 May;21(5):309-15 – reference: 20085587 - Cancer Sci. 2010 Mar;101(3):579-85 – reference: 22561520 - Nat Genet. 2012 May 06;44(6):690-3 – reference: 25369307 - Semin Liver Dis. 2014 Nov;34(4):456-64 |
SSID | ssj0017808 |
Score | 2.3352668 |
Snippet | Background
Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late,... Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late, unresectable... Background Thailand has a high incidence of cholangiocarcinoma (CCA), particularly in the north and northeastern regions. Most CCA patients come at a late,... |
SourceID | unpaywall pubmedcentral proquest gale pubmed crossref springer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 346 |
SubjectTerms | Adult Antigens Bans Bile Duct Neoplasms - diagnostic imaging Bile Duct Neoplasms - mortality Bile Duct Neoplasms - surgery Bile ducts Bile Ducts, Intrahepatic - diagnostic imaging Biomedical and Life Sciences Biomedicine Cancer Cancer Research Cancer therapies Cholangiocarcinoma Cholangiocarcinoma - diagnostic imaging Cholangiocarcinoma - mortality Cholangiocarcinoma - surgery Diagnosis Disease-Free Survival Early Detection of Cancer Endemic Diseases Epidemiology Female Health Promotion and Disease Prevention Hepatitis Hospitals Humans Liver cancer Magnetic resonance imaging Male Medicine/Public Health Middle Aged Oncology Phosphatase Population prevention and public health Prospective Studies Research Article Surgical Oncology Ultrasonic imaging Ultrasonography Ultrasound imaging |
SummonAdditionalLinks | – databaseName: Health & Medical Collection (ProQuest) dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1Lj9MwELZgkWA5IN4bWGBASEgs0ebhOA4XtEKsFqTlAFTqLXJsp1Rqk1K3QvxDfhYzqRualVguOTRjN4nH3zw9w9hLkddJmkU25Lmp8BIVoTJ1FuapyIvaClV05RjOP4uzEf80zsbe4eZ8WuUWEzugNq0mH_lxLDtpmMbi3eJHSF2jKLrqW2hcZddiVFWIq_Nxb3DFuYykj2TGUhw7xGJJqWoiTNDUD5OBLLqIyDsi6WK6ZB8zvclurJuF-vVTzWY7Yun0Nrvl9Uk42TDAHXbFNnfZ9XMfMb_Hfo9mOJuj5kmACIFWK04JqKlCZ9U2kykKsyXStnMFmvpdg7EUWIDF0s5RSZ9QpgzMLHnVHCicxlJN5BC1yokFH99xQP5ccGsEHmRdqBBB6-nKvQUFi75FWEgi0-DE7fZ8J3TVbaGtgb_BLY8TVOQXcjBt8K-A3PPzqQaFmu19Njr98O39Wei7N4RaRMkKl1xVsRZ1LS03qHaliucqs2jixYnBbxmrqDCZElWCBro0XMdKF1ZTJkAkaqPSB2yvaRt7wEBXGYI2XmuVIcZIqTLUcjKO2lClueEBi7brWGpf2pw6bMzKzsSRotwsfUnpbLT0ZRKw1_2Qxaaux2XEz4g5ys3R1B4TyhMupCwkqkABe9FRUEWNhlJ2JmrtXPnx65cB0StPVLf4eFr5ExAtLQn-vkt5OKDELa-Ht7dcWnrIceXfDRKw5_1tGklpdI1t10iDaEzSrcgC9nDD1P3bJzmquoIXAcsH7N4TUCHy4Z1m-r0rSM4lVXnDkUfbjbHzWP_-qEf93vn_Ejy6_JUfs_2E9jW5x5JDtrdaru0T1BZX1dMOEv4AY7NqGQ priority: 102 providerName: ProQuest – databaseName: Springer Nature OA Free Journals dbid: C6C link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3di9NAEF_kBD8exG-jp44iCN4Fk3Sz2fh2FI9TOB_Uwr2FzWZTC21SmhbxP_TP8jdpGprDD3zJQzM7TTI7M7_ZmZ0V4pVKymgUB86XSZHjEqS-KcrYT0YqSUunTNq2Yzj_pM4m8uNFfNE1i-a9MPv5-1Crtw3sp-byMuVHCM99WNurMewuV--N1bhPGCQ60F3S8rfDBm7nsvHd8z6XKyP79OhNcX1TLc2P72Y-3_NAp7fFrQ460slW1nfEFVfdFdfOu-T4PfFzMge3hs9JIhgDBKhgSQCl1Aaw1XQGv7UCbb0wZPloayoc5xBouXIL4PEpF8XQ3PECWkMGbBy3P_YBIKeOulROQ7x0S80GNgazlHIYy3K2bt6RoWV_GpjP3rEA43q3lZPaRrZUlySPod1gkPMSUEOzCn9FvBK_mFkyALH3xeT0_dfxmd8d1OBbFURrSNfkoVVlqZ0sgLBGRiYmdojmwqjAtwxNkBaxUXmEWFwX0obGps5y0j9QZWFGD8RBVVfukSCbx7DPuJYmhjnR2sQANLEE8MmtLKQngp0cM9t1MefDNOZZG81olW1Fn3HlGos-izzxph-y3Lbw-Bvxc54c2XYXaq_-2YlUWqcaaMcTL1sKbp5RcXXO1GyaJvvw5fOA6HVHVNZ4PGu6zQ41iwS_71MeDiih3XZ4ezdLs866NFmoW2Q4CpUnXvS3eSRXzFWu3oAGhpcdWRp74uF2UvdvHyVAtUqmnkgG070n4J7jwzvV7Fvbe1xqbuiGkUc7xdh7rD9_1KNed_4tgsf_xfuJuBGxmvPCWHQoDtarjXsKnLjOn7UW4hcNxmKt priority: 102 providerName: Springer Nature – databaseName: Unpaywall dbid: UNPAY link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ri9QwEA_HHvj44PtRPTWKIHh2r-2maeq3RTxP4Q5RF-4-lTRN9sp122W7RfQv9M9ypi-2iw8Ev5RlM0kfyfxmJvMIIc95YLyJ72ibBUkMFye0ZWJ8O5jwIDSay7Aux3B8wo9m7MOpf7pD3nW5MPECh1R6Nd5MP89qzIYf6uJgmZiG1QU_KAFdBQafcdsD490GLN7l6Gkakd3ZycfpWZ1bFLjoQwhan-Yv-w2k0jY2bwin7cDJ3nt6lVyu8qX89lVm2YaAOrxOzrtXa-JSLsbVOh6r71tVH__Du98g11ollk6bVXeT7Oj8Frl03Lrpb5MfswxGKvHEJgqwBKYyPD0F9ZjWpnQ-T0GCroC2WEiq8JBtmmj0ZtDlSi_AMphjeA7NNG7llVTCMBoLMdugys41bZ1KJcVNZFpWgHbALzQG2DbpunxNJV3255LZKKcTGLjokkppXVKXFoayV4AzMECMm1ElTXO4FUWfwCJVVII6fYfMDt9-eXNkt0dG2Io73hrWmYxdxY0RmiWg600kC6Svwa50vQQ-qCudMPEljz0eOiJhypUq1ArDDxxuEjm5S0Z5kev7hKrYB0kBVyN9ADYhpA-qlc9ABYsVS5hFnG7JRKqtp47HemRRbVcJHjUzFGEMHc5Q5FnkZd9l2RQT-RPxE1yHUZMP2wNRNGVciFCA3mWRZzUFlvHIMU5oLquyjN5__jQgetESmQIXkWzTLgqcEvh_k3JvQAk4o4bNHUNELc6VkStqHXXicos87ZuxJ8bu5bqogAZEAIrU0LfIvYZ_-rf3AtCvOQstEgw4qyfA6ufDljw9r6ugM4Gl5aDnfseDG4_1-4-637Pp36fgwT9RPyRXPORG3KLz9shovar0I9BY1_HjFo1-AhNhki8 priority: 102 providerName: Unpaywall |
Title | Ultrasound screening for cholangiocarcinoma could detect premalignant lesions and early-stage diseases with survival benefits: a population-based prospective study of 4,225 subjects in an endemic area |
URI | https://link.springer.com/article/10.1186/s12885-016-2390-2 https://www.ncbi.nlm.nih.gov/pubmed/27251649 https://www.proquest.com/docview/1800710316 https://www.proquest.com/docview/1793911195 https://pubmed.ncbi.nlm.nih.gov/PMC4890519 https://bmccancer.biomedcentral.com/track/pdf/10.1186/s12885-016-2390-2 |
UnpaywallVersion | publishedVersion |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
journalDatabaseRights | – providerCode: PRVADU databaseName: BioMed Central customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: RBZ dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.biomedcentral.com/search/ providerName: BioMedCentral – providerCode: PRVAFT databaseName: Open Access Digital Library customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: KQ8 dateStart: 20010101 isFulltext: true titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html providerName: Colorado Alliance of Research Libraries – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: DOA dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVEBS databaseName: EBSCOhost Academic Search Ultimate customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: ABDBF dateStart: 20010101 isFulltext: true titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn providerName: EBSCOhost – providerCode: PRVBFR databaseName: Free Medical Journals customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: DIK dateStart: 20010101 isFulltext: true titleUrlDefault: http://www.freemedicaljournals.com providerName: Flying Publisher – providerCode: PRVFQY databaseName: GFMER Free Medical Journals customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: GX1 dateStart: 0 isFulltext: true titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php providerName: Geneva Foundation for Medical Education and Research – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: M~E dateStart: 20010101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVAQN databaseName: PubMed Central customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: RPM dateStart: 20010101 isFulltext: true titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/ providerName: National Library of Medicine – providerCode: PRVPQU databaseName: Health & Medical Collection customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: 7X7 dateStart: 20090101 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: http://www.proquest.com/pqcentral?accountid=15518 eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: BENPR dateStart: 20090101 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVFZP databaseName: Scholars Portal Journals: Open Access customDbUrl: eissn: 1471-2407 dateEnd: 20250930 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: M48 dateStart: 20010801 isFulltext: true titleUrlDefault: http://journals.scholarsportal.info providerName: Scholars Portal – providerCode: PRVAVX databaseName: Springer Nature HAS Fully OA customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: AAJSJ dateStart: 20011201 isFulltext: true titleUrlDefault: https://www.springernature.com providerName: Springer Nature – providerCode: PRVAVX databaseName: Springer Nature OA Free Journals customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: C6C dateStart: 20011201 isFulltext: true titleUrlDefault: http://www.springeropen.com/ providerName: Springer Nature – providerCode: PRVAVX databaseName: SpringerLink Journals (ICM) customDbUrl: eissn: 1471-2407 dateEnd: 99991231 omitProxy: true ssIdentifier: ssj0017808 issn: 1471-2407 databaseCode: U2A dateStart: 20011201 isFulltext: true titleUrlDefault: http://www.springerlink.com/journals/ providerName: Springer Nature |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1tb9MwELbGKvHyAfFOYRSDkJAYgSZ1HAcJoa7aNJBaTYNIhS-RkzilUpuUphXsH_KzeC5NQzuNly-WGp-d1D4_d_ad7xh7Jr3U6bhtYwkviVC0fUsnqWt5Hen5qZHaL8Mx9AfyOBAfhu5wh63TW1UDWFy4taN8UsF88urHt7N3WPBvywWv5OsCGKvIBU1aDrbwFhC5AcHkEJP3xW-jgqfKBHU28JiMCl5l5Lywiy0xdR6sN6TVeU_K2px6jV1ZZjN99l1PJhsS6-gGu16pmry74o2bbMdkt9jlfmVMv81-BhP0VlBeJQ7wwIYWXXIosbwclWw0hpybgzafah5TKmyeGLI58NncTKG_j8iJhk8MHbgVXKMbQ-GSLSicI8Mr00_B6aiXF0tgEriaRwDXdLwo3nDNZ3X2MIukaYKO8_XVT14GvuV5ysVLoAE6iOjIqODjDK_idHI_HcdcQ-m9w4Kjw0-9Y6tK7GDFsu0swA06smOZpsqIBBpZRwtPuwa7P9tJMJa2bvuJq2XkYO-uEhHbOvZNTE4CbZkmunOX7WZ5Zu4zHkcu8Bxlql3Aj1LahQLkCihKUSwS0WTt9TyGcRX1nJJvTMJy96NkuJr6kDzdaOpDp8le1E1mq5AffyN-TMwRrm6t1nARdoVUylfQjprsaUlBwTYy8uYZ6WVRhO8_nm4RPa-I0hyfF-vqckROU4Lnm5R7W5RAg3i7es2l4XoxhbYqNcmOLZvsSV1NLcnDLjP5EjQAahJ8vttk91ZMXf97x4MWLIXfZN4Wu9cEFKN8uyYbfy1jlQtFAeDQcn-9MDY-68-Dul-vnX9PwYP_HruH7KpDS5wO0Zw9truYL80j6JSLqMUueUOvxRoHh4OTU_zqyV6rPJ9plRiC8vTgC8rAwZNGMDjpfv4Ff-x7MQ |
linkProvider | Scholars Portal |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwELfGkBg8IL4JDGYQCGkjWj4cx0FCaAKmlq17gFXqW3Bsp1Rqk9K0mvZP8XfwZ3GXL5pJjKe95KE-u07O_t2d73xHyCsepp4fOMZmoU7g4US21Glghz4Po9RwGZXpGAYnvDdkX0bBaIP8au7CYFhlg4klUOtc4Rn5vitKaei7_MP8p41Vo9C72pTQqJbFkTk_A5OteN__BPx97XmHn08_9uy6qoCtuOMtYSoycRVPU2GYBnXAlyyUgQHTw_W0VsaVTqQDyRMPDEehmXKlioxCD7XDUy19GPcauc58h2Gu_nDUGnhuKBxRe05dwfcLwH6BoXHc9vzIsb2O7LsoAdZE4MXwzNZHe4tsrbK5PD-T0-maGDy8Q27X-is9qBbcXbJhsnvkxqD20N8nv4dTGK3AYk0UEAmsZBiSgmZMSys6G09AeC6ANp9JqrC-NtUGHRl0vjAzMArGGJlDpwZP8QoqYRiDOZht0GLHhtb-pILi-TEtVgB0sFVoAoidTpbFOyrpvC1JZqOI1jBw3twnpWU2XZqnlL0FiIEBEjyHKugkg7-i6A6YTRSVoEk_IMMr4etDspnlmXlMqEoCEBLwTGUAmCaEDECrChhoX4limlnEafgYqzqVOlb0mMalSSV4XLE-xvA5ZH3sWWS37TKv8ohcRryDiyOursK2GBQfMC5EJEDlssjLkgIzeGQYIjSWq6KI-9--doje1ERpDtNTsr5xkSNL4Pd1yu0OJUCM6jY3qzSuIa6I_25Ii7xom7Enhu1lJl8BDaA_StMosMijalG3b--FoFpzFlkk7Cz3lgATn3dbssmPMgE6E5hVDnruNRtjbVr__qh77d75PwueXP7KO2Srdzo4jo_7J0dPyU0P9zgezXnbZHO5WJlnoKkuk-clPFDy_arx6A8jD6hr |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlR1db9Mw0EKbNOAB8U3GYAYhITGiJanjOLxVQLUVNiFGpb1ZjmN3ldqkaloh_iE_i7vEiZqJD_GSh-Z8TXLfvvMdIa94YqNBHBifJXkGlyD1VW5jPxnwJLWGq7Rux3B2zk8mbHwZX7o5p1Vb7d6mJJszDdilqVgfL3PbiLjgxxVoVYFFZ9yPIGj3QQfvijjlEH3tDofji3GXSEhEIFwy87cLe-boulLeskrXKya7tOltcnNTLNWP72o-37JMo7vkjnMp6bDhgXvkhinuk70zlzR_QH5O5oCtwvlJFJQEBK6AkoKzSuvAtpjOwJ6tALZcKKpx5DXNDeYW6HJlFuCnT7FYhs4NbqxVVAEag22RfXAsp4a6FE9FcUuXVhvQPcC9NAMlamfr6h1VdNlNCfPRauaAuGyPeNK6wS0tLWVvQeoBQYZbQxWdFfBXFHfoFzNNFTi3D8lk9PHb-xPfDXDwNQ-iNVBdZaHm1grDcvC8BoolKjYQ5YVRDt8yVEGax4pnEcToImc6VDo1GosBAm5zNXhEdoqyME8I1VkMehuuVsWgZoRQMTg6MQOHKNMsZx4JWjpK7bqb45CNuayjHMFlQ3qJFW1Iehl55E23ZNm09vgb8CEyh2xOp3ZqQQ4ZFyIV4AV55GUNgU01CqzamapNVcnTi689oNcOyJbweFq5QxAlkgR-34Y86EGC1Ov-7ZZLpdM6lQxF7TEOQu6RF91tXImVdIUpNwADChkNXBp75HHD1N3bRwl4u5ylHkl67N4BYC_y_p1idlX3JGcCG73ByqNWMLYe688f9aiTnX-TYP-_cB-SvS8fRvLz6fmnp-RWhBKPe2fRAdlZrzbmGbiS6-y5Uxe_ADcBb1g |
linkToUnpaywall | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3ri9QwEA_HHvj44PtRPTWKIHh2r-2maeq3RTxP4Q5RF-4-lTRN9sp122W7RfQv9M9ypi-2iw8Ev5RlM0kfyfxmJvMIIc95YLyJ72ibBUkMFye0ZWJ8O5jwIDSay7Aux3B8wo9m7MOpf7pD3nW5MPECh1R6Nd5MP89qzIYf6uJgmZiG1QU_KAFdBQafcdsD490GLN7l6Gkakd3ZycfpWZ1bFLjoQwhan-Yv-w2k0jY2bwin7cDJ3nt6lVyu8qX89lVm2YaAOrxOzrtXa-JSLsbVOh6r71tVH__Du98g11ollk6bVXeT7Oj8Frl03Lrpb5MfswxGKvHEJgqwBKYyPD0F9ZjWpnQ-T0GCroC2WEiq8JBtmmj0ZtDlSi_AMphjeA7NNG7llVTCMBoLMdugys41bZ1KJcVNZFpWgHbALzQG2DbpunxNJV3255LZKKcTGLjokkppXVKXFoayV4AzMECMm1ElTXO4FUWfwCJVVII6fYfMDt9-eXNkt0dG2Io73hrWmYxdxY0RmiWg600kC6Svwa50vQQ-qCudMPEljz0eOiJhypUq1ArDDxxuEjm5S0Z5kev7hKrYB0kBVyN9ADYhpA-qlc9ABYsVS5hFnG7JRKqtp47HemRRbVcJHjUzFGEMHc5Q5FnkZd9l2RQT-RPxE1yHUZMP2wNRNGVciFCA3mWRZzUFlvHIMU5oLquyjN5__jQgetESmQIXkWzTLgqcEvh_k3JvQAk4o4bNHUNELc6VkStqHXXicos87ZuxJ8bu5bqogAZEAIrU0LfIvYZ_-rf3AtCvOQstEgw4qyfA6ufDljw9r6ugM4Gl5aDnfseDG4_1-4-637Pp36fgwT9RPyRXPORG3KLz9shovar0I9BY1_HjFo1-AhNhki8 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ultrasound+screening+for+cholangiocarcinoma+could+detect+premalignant+lesions+and+early-stage+diseases+with+survival+benefits%3A+a+population-based+prospective+study+of+4%2C225+subjects+in+an+endemic+area&rft.jtitle=BMC+cancer&rft.au=Sungkasubun%2C+Prakongboon&rft.au=Siripongsakun%2C+Surachate&rft.au=Akkarachinorate%2C+Kunlayanee&rft.au=Vidhyarkorn%2C+Sirachat&rft.date=2016-06-02&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2407&rft.eissn=1471-2407&rft.volume=16&rft.issue=1&rft_id=info:doi/10.1186%2Fs12885-016-2390-2&rft.externalDocID=A468898152 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2407&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2407&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2407&client=summon |